In the sixth blog in our series looking at the story behind the EFPIA Manifesto, Koen Berden, Executive Director for International Affairs at EFPIA highlights the importance of a smart trade agenda to promote investment. We believe such an agenda is vital to create the necessary framework conditions to support national health care systems under pressure from the prevalence of chronic diseases and ageing populations.
The often-heard critique with respect to trade policy is that it is very high-level and abstract with limited relevance for real-life challenges that patients face. So, let’s turn the starting point around and begin from the perspective of the patient.
Negotiators agreed a draft text Thursday on the post-Brexit relationship between Britain and the European Union, paving...
Read more
About the EFPIA newsletter
The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.